Quantcast
Last updated on April 19, 2014 at 18:42 EDT

Latest Fludeoxyglucose Stories

2011-12-21 22:50:49

Positron emission tomography (PET) and a molecular imaging agent that captures the proliferation of cancer cells could prove to be a valuable method yet for imaging a form of Non-Hodgkin´s disease called mantle cell lymphoma, a relatively rare and devastating blood cancer. The pilot study is published in the December issue of The Journal of Nuclear Medicine. Lymphoma is the term used for an array of cancers that affect blood cells and the lymphatic system. These cancers are typically...

2011-12-01 12:59:48

New research finds a marker used to detect plaque in the brain may help doctors make a more accurate diagnosis between two common types of dementia — Alzheimer's disease and frontotemporal lobar degeneration (FTLD). The study is published in the November 30, 2011, online issue of Neurology®, the medical journal of the American Academy of Neurology. "These two types of dementia share similar symptoms, so telling the two apart while a person is living is a real challenge, but...

2011-11-17 03:43:58

2 Penn Medicine studies articulate efficacy of non-invasive MRI test for Alzheimer's On the quest for safe, reliable and accessible tools to accurately diagnose Alzheimer's disease, researchers from the Perelman School of Medicine at the University of Pennsylvania found a new way of diagnosing and tracking Alzheimer's disease, using an innovative magnetic resonance imaging (MRI) technique called Arterial spin labeling (ASL) to measure changes in brain function. The team determined that the...

2011-10-27 07:00:00

SAN DIEGO, Oct. 27, 2011 /PRNewswire/ -- The Breast journal published new data from a prospective study conducted at the Seoul National University College of Medicine in Korea that shows Positron Emission Mammography (PEM) has a higher sensitivity for tumor detection compared to whole-body PET/CT when using both visual as well as quantitative analysis. These results were particularly striking and significant for smaller-sized tumors (less than 2 cm), likely due to the improved spatial...

2011-10-05 14:01:00

CLEVELAND, Oct. 5, 2011 /PRNewswire/ -- Advanced imaging with Positron Emission Tomography (PET) scans shows great promise in predicting which patients with inoperable lung cancer have more aggressive tumors and need additional treatment following standard chemotherapy/radiation therapy, according to new research. Mitch Machtay, MD, of the Seidman Cancer Center at University Hospitals (UH) Case Medical Center and principle investigator for the study, presented the significant data today...

2011-08-17 17:19:00

ORLANDO, Fla., Aug. 17, 2011 /PRNewswire/ -- Local branding & marketing agency, FDG {Creative}, videographer/photographer JonPaul Douglass, and musician Matthew Heafy have created a collaborative entry in the Urban Land Institute's "Why I Love ULI" video contest. The 1:23 minute video depicts appreciation for all the Urban Land Institute does for "The City Beautiful" by featuring FDG friends, clients, and special guest star, Mayor Buddy Dyer, in a fun and refreshing montage "loving"...

2011-08-02 07:00:00

SAN DIEGO, Aug. 2, 2011 /PRNewswire/ -- Published last week in the American Journal of Roentgenology, researchers from Swedish Cancer Institute and the University of Washington showed that using Positron Emission Mammography (PEM) they found a correlation between FDG uptake values and the prognostic factors that predict breast cancer survival. The highest FDG levels were in the most aggressive cancer type - triple negative cancers. Women with triple negative breast cancer have a higher...

2011-07-08 09:30:00

SALT LAKE CITY, July 8, 2011 /PRNewswire/ -- Garb Oil & Power Corporation ("Garb") (OTCQB: GARB) has completed its due diligence and has made an offer to buy FDG di Collu S.r.l., and Carbus S.r.l., for euro 10,500,000. Upon review of the offer FDG di Collu S.r.l., and Carbus S.r.l., rejected the offer as too low. Further negotiations did not resolve the issue. In consideration of the above Garb's board has informed FDG and Carbus that Garb has terminated negotiations to acquire FDG and...

2011-07-07 08:35:00

CULVER CITY, Calif., July 7, 2011 /PRNewswire/ -- Sofie Biosciences, developer of molecular imaging systems and probes, has been awarded a 2011 Phase I Small Business Innovation Research grant from the Department of Energy. Of the 2,163 applications received in response to their funding notice, only 197 were selected to receive Phase I grants. (Logo: http://photos.prnewswire.com/prnh/20101208/LA13841LOGO) Positron Emission Tomography (PET) is a molecular imaging modality that utilizes...

2011-06-07 14:45:00

SAN ANTONIO, June 7, 2011 /PRNewswire/ -- Presented today at the Society of Nuclear Medicine 2011 Annual Meeting researchers from Swedish Medical Center and the University of Washington showed that FDG dose for Positron Emission Mammography (PEM) may be reduced by at least 50% without altering image quality. PEM is the breast application of the Naviscan high-resolution PET scanner showing the location as well as the metabolic phase of a lesion. The metabolic view assists physicians in...